Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite α-Blocker Treatment in Patients With BPH: The ADDITION STUDY-Reference-Cited by-同舟云学术

Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite α-Blocker Treatment in Patients With BPH: The ADDITION STUDY

Published:2013-10 Issue:4 Volume:82 Page:887-893
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Takeda Masayuki,Nishizawa Osamu,Gotoh Momokazu,Yoshida Masaki,Takahashi Satoru,Masumori Naoya

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community;Bosch;Urology,1995

2. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study;Boyle;BJU Int,2003

3. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study;Welch;Urology,2002

4. The relationship between lower urinary tract symptoms and health status: the UREPIK study;Boyle;BJU Int,2003

5. Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract;Engström;BJU Int,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electroencephalography‐based investigation of the effects of oral desmopressin on improving slow‐wave sleep time in nocturnal polyuria patients (the DISTINCT study): A single‐arm, open‐label, single‐assignment trial;Neurourology and Urodynamics;2024-04-12

2. Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30

3. Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan;International Journal of Clinical Pharmacy;2023-09-15

4. Association between α1-adrenoceptor antagonists and delirium: Analysis of the Japanese Adverse Event Report database;2023-04-21

5. Comparison of Efficacy and Safety of a Combination of Tamsulosin and Mirabegron versus Tamsulosin Alone in the Management of Overactive Bladder in Males with Lower Urinary Tract Symptoms – TAME-Overactive Bladder: An Open-labeled Randomized Controlled Trial;International Journal of Applied & Basic Medical Research;2023